Mark Anthony McCamish - Director at Avadel Pharmaceuticals Plc

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
AVDL on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Mark Anthony McCamish since 11/21/2024

Holdings reported by Mark Anthony McCamish for Avadel Pharmaceuticals Plc

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Ordinary Shares 67K $635K $9.47 Jul 29, 2025 By Matthew 5 LLC
Ordinary Shares 22K $208K $9.47 Jul 29, 2025 Direct
Stock Option (Right to Buy) 11K Jul 29, 2025 Direct Ordinary Shares

Transactions reported by Mark Anthony McCamish for Avadel Pharmaceuticals Plc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.